<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">22066036</PMID>
        <DateCompleted>
            <Year>2011</Year>
            <Month>11</Month>
            <Day>10</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2019</Year>
            <Month>02</Month>
            <Day>26</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2036-3613</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>3</Volume>
                    <Issue>3</Issue>
                    <PubDate>
                        <Year>2011</Year>
                        <Month>Jul</Month>
                        <Day>11</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Rare tumors</Title>
                <ISOAbbreviation>Rare Tumors</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Efficacy of trabectedin in metastatic solitary fibrous tumor.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e29</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.4081/rt.2011.e29</ELocationID>
            <Abstract>
                <AbstractText>Solitary fibrous tumor is a rare tumor type and has an unpredictable course. Local recurrence rate varies between 9 and 19%, and rate of metastatic involvement between 0 and 36 %. It is characterized by a typical architecture and immuno-histochemistry tests. The most important prognostic factor is the complete resection of primary tumor. Treatment of recurrences is not clearly established. If a solitary fibrous tumor is too advanced to allow surgical resection, radiotherapy and chemotherapy may be used. The most often used drugs are doxorubicine and\or ifosfamide. We report the case of man with metastatic solitary fibrous tumor treated with trabectedin, administered at a dose of 1.5 mg/m² every 3 weeks. After 3 cycles, metastases had significantly decreased. Recurrence of the disease was demonstrated 8 months after the start of trabectedin. This case shows that trabectedin is a possible treatment option.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Chaigneau</LastName>
                    <ForeName>Loïc</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medical Oncology, Universitary Hospital Center J. Minjoz, Besançon, France;</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kalbacher</LastName>
                    <ForeName>Elsa</ForeName>
                    <Initials>E</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Thiery-Vuillemin</LastName>
                    <ForeName>Antoine</ForeName>
                    <Initials>A</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Fagnoni-Legat</LastName>
                    <ForeName>Christine</ForeName>
                    <Initials>C</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Isambert</LastName>
                    <ForeName>Nicolas</ForeName>
                    <Initials>N</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Aherfi</LastName>
                    <ForeName>Lionel</ForeName>
                    <Initials>L</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pauchot</LastName>
                    <ForeName>Julien</ForeName>
                    <Initials>J</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Delroeux</LastName>
                    <ForeName>Delphine</ForeName>
                    <Initials>D</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Servagi-Vernat</LastName>
                    <ForeName>Stephanie</ForeName>
                    <Initials>S</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mansi</LastName>
                    <ForeName>Laura</ForeName>
                    <Initials>L</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pivot</LastName>
                    <ForeName>Xavier</ForeName>
                    <Initials>X</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D002363">Case Reports</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2011</Year>
                <Month>07</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Rare Tumors</MedlineTA>
            <NlmUniqueID>101526926</NlmUniqueID>
            <ISSNLinking>2036-3605</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">metastatic solitary fibrous tumor</Keyword>
            <Keyword MajorTopicYN="N">trabectedin.</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2011</Year>
                <Month>06</Month>
                <Day>11</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2011</Year>
                <Month>06</Month>
                <Day>25</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2011</Year>
                <Month>07</Month>
                <Day>01</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2011</Year>
                <Month>11</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2011</Year>
                <Month>11</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2011</Year>
                <Month>11</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">22066036</ArticleId>
            <ArticleId IdType="doi">10.4081/rt.2011.e29</ArticleId>
            <ArticleId IdType="pii">rt.2011.e29</ArticleId>
            <ArticleId IdType="pmc">PMC3208416</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>J Clin Oncol. 2009 Sep 1;27(25):4188-96</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19652065</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mod Pathol. 1999 Nov;12(11):1034-42</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10574600</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Surg Pathol. 1989 Aug;13(8):640-58</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2665534</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hum Pathol. 1999 Dec;30(12):1464-73</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10667425</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hum Pathol. 1995 Apr;26(4):440-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7705824</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Oncol. 2010 Jul 1;28(19):3107-14</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20516432</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Histopathology. 1991 Dec;19(6):515-22</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1786936</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hum Pathol. 2000 Sep;31(9):1108-15</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11014579</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Surg Pathol. 1995 Nov;19(11):1257-66</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7573687</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Anticancer Drugs. 2002 May;13 Suppl 1:S3-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12173491</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Oncologist. 2005 Nov-Dec;10 (10 ):827-32</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16314293</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Surg Pathol. 2000 Jul;24(7):971-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10895819</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>